IndiaTickerLatest filing: Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aarey Drugs & Pharmaceuticals Limited
ObservedCompany dossier
Aarey Drugs & Pharmaceuticals
NSE:AAREYDRUGS · ISIN INE198H01019
- Close
- ₹75.61 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aarey Drugs & Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹133.8 Cr · PAT ₹0.7 Cr.
Exchange XBRLLatest ownership: promoter group 37.71% and public 62.29% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aarey Drugs & Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing Aarey Drugs & Pharmaceuticals Ltd - 524412 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Disclosure under SEBI Takeover Regulations - Aarey Drugs & Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing Disclosure under SEBI Takeover Regulations - Aarey Drugs & Pharmaceuticals Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹133.8 Cr
- Profit after tax
- ₹0.7 Cr
- EPS
- ₹0.26
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 37.71%
- Public
- 62.29%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL